2BB score and signals
Collegium Pharmaceutical, Inc.’s current 2BB score is 69 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 78 | High |
| Momentum | 62 | Improving |
| Financial strength | 69 | Strong |
| Quality | 98 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Founded | 2002 |
| Employees | 423 |
| P/E ratio | 18.33 |
| 52-week range | $21.43 – $50.79 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | 1.9599 | — | $229.74M |
| 2026-11-05 | — | 1.8496 | — | $222.77M |
| 2026-08-06 | — | 1.7495 | — | $205.23M |
| 2026-05-07 | 1.76 | 1.6232 | $193.52M | $189.70M |
Related companies